Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab + MTX in RA (RA-MOBILITY)
NCT01061736Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2010
- Primary completion
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 36
01
Overview
A Phase 3 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Mar 2010; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01061736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061736.